Genentech Caps Cost of Cancer Drug for Some Patients
New York Times 2006 October 12; p C2
Showing items related by title, author, creator and subject.
Pollack, Andrew (2002-09-07)
In Costly Cancer Drug, Hope and a Dilemma: Some Pay Up to $100,000 a Year for Avastin's Arguable Benefits Kolata, Gina; Pollack, Andrew (2008-07-06)
Pollack, Andrew (1988-06-23)